Elanco Animal Health Incorporated Common Stock
Here’s whether Elanco Animal Health Incorporated Common Stock (ELAN) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.
Positives: trading above the 200-day MA (long-term uptrend intact); 50-day MA is rising (+0.58% over 10 days); RSI 41 — healthy momentum range; strong 1-year return of +31.5%; 3-month momentum positive (+19.2%); rising volume confirms the move (1.70x 30d avg). Concerns: below the 50-day MA (medium-term momentum negative). Currently 15.4% off its 52-week high. Score: +6/7.
ELAN is holding above its long-term 200-day MA ($23.57) but has slipped below the 50-day MA ($24.54), pointing to short-term weakness in an otherwise intact trend. An RSI of 40.7 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +31.5% compares to +20.4% for SPY (beat the market by 11.1%).